SERCA2 ATPase Antibody

About the Target

ATP2A2 is a target of interest in many antibody-based workflows. SERCA2 (Sarco/Endoplasmic Reticulum Ca2+-ATPase 2) is a membrane-bound P-type ATPase predominantly expressed in cardiac and smooth muscle, where it plays a critical role in calcium homeostasis by actively pumping cytosolic Ca2+ into the sarco/endoplasmic reticulum (SR/ER), thus regulating muscle contraction and relaxation. SERCA2 contains ten transmembrane helices creating a channel for Ca2+ transport, along with three cytoplasmic domains (actuator, phosphorylation, and nucleotide-binding domains) responsible for ATP hydrolysis and conformational changes required for active transport. Depending on the literature source, ATP2A2 may also be discussed as SERCA2 ATPase and ATP2B.

Reported cellular context includes endoplasmic reticulum, membrane, and sarcoplasmic reticulum, which can matter when signal is compared across treatments or changing cell states. Following ATP2A2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

ATP2A2 is commonly interpreted in the context of cardiovascular and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans endoplasmic reticulum, membrane, and sarcoplasmic reticulum, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between endoplasmic reticulum, membrane, and sarcoplasmic reticulum across matched conditions
• changes linked to vascular, contractile, or hemodynamic cell-state cues
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for ATP2A2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in ATP2A2 reflect biology rather than handling. When interpreting ATP2A2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep ATP2A2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.